The nation’s third trial of an Actos lawsuit involving allegations
that long-term use of the Type 2 diabetes drug can cause bladder cancer
is now underway in the Eighth Judicial District Court of Nevada for Clark
County. The lawsuit was brought on behalf a patient who began taking Actos
before bladder cancer warnings were added to the drug’s label in
2011.The complaint accuses Takeda Pharmaceuticals of concealing knowledge
of an association between Actos and bladder cancer until the company was
forced to make the 2011 label change. The jury hearing the Actos lawsuit
is expected to begin deliberations by the middle of December.
Court records indicate that more than 3,000 Actos lawsuits involving bladder
cancer allegations have been filed in courts around the country. More
than 2,500 of those claims are pending in a multidistrict litigation now
underway in U.S. District Court, Western District of Louisiana. That litigation’s
first " bellwether" trials are scheduled to begin next year.
According to court documents, two other Actos lawsuits have gone to trial
at the state level, both of which ended with jury decisions favoring plaintiffs.
However, a $6.5 million verdict awarded to a Plaintiff in California Superior
Court in April was set aside by the judge overseeing the case, and is
currently on appeal.
A second trial involving Actos and bladder cancer concluded in Maryland
State Court in September, with $1.7 million being awarded to the family
of a man who died of the disease. However, according to court records,
the judge presiding over that trial overturned the verdict in accordance
with Maryland law because the jury also found that the decedent’s
decades-long smoking habit contributed to the development of the disease.
According to court documents, the Actos litigation began to grow after
the U.S. Food & Drug Administration (FDA) warned in June 2011 that
use of the drug for 12 months or more had been associated with an increased
risk of the disease. At that time, the FDA ordered Takeda Pharmaceuticals
to add new warnings to the Actos label about its potential to cause bladder cancer.
Long-term users of Actos who have been diagnosed with bladder cancer may
be eligible to file an Actos lawsuit against Takeda Pharmaceutical.
For more information about ACTOS, please contact Hutton Law Offices to
learn more about
mass torts and how you can recover compensation.